USP Comments to FDA on Docket No. FDA-2019-D-2397; Using the Inactive Ingredient Database; Draft Guidance for Industry. Comments were submitted in 2019.
USP-comments-for-FDA-on-IID-draft-guidance.pdf
(201.95 KB)
Public Policy